Aster Insights Announces that The University of Kansas Cancer Center will join the Oncology Research Information Network (ORIEN)

Aster Insights, a provider of technology-enabled data and analytics solutions for oncology discovery, has announced that The University of Kansas Cancer Center will join its Oncology Research Information Exchange Network (ORIEN). The KU Cancer Center is the latest NCI-designated cancer center to join ORIEN, which is comprised of 18 cancer centers across the U.S. dedicated to collaborative research to accelerate cancer discovery and development.

Launched in 2014, Aster Insights’ ORIEN platform is the largest and longest-running academic cancer research consortium of its kind in the United States. ORIEN members participate in the Total Cancer Care (TCC) protocol, the largest lifetime-consented patient research program in oncology, utilizing deep clinical and genomic data to best support patient care, research, and discovery.

Aster Insights is the only company offering ongoing data and specimen collection from cancer patients across ORIEN, creating one of the most diverse data sets of patients treated in academic cancer centers across the U.S. To date, more than 380,000 patients representing dozens of different types of cancer have enrolled in the TCC protocol, giving ORIEN members, Aster Insights, and its partners access to this resource.

“The KU Cancer Center is an important addition as ORIEN grows in its national footprint and expands into new lanes of scientific expertise,” said Aster Insights CEO Dr. Anand Shah. “Through ORIEN, we are able to generate unmatched scientific and clinical intelligence that is changing oncology in real time.”

“The KU Cancer Center is proud to join ORIEN and work alongside this outstanding network of academic cancer centers,” said Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center. “Collaboration in cancer research leads to critical breakthroughs that are changing the lives of patients with cancer worldwide. ORIEN offers us a unique opportunity to partner with key stakeholders in academia, industry, and most importantly, patients, to change the way we treat, and cure, cancer.”

The KU Cancer Center officially joined ORIEN on May 21, 2023.

Read the original press release here.